Skip to main content

Table 2 Genome profile results of the 10 patients

From: Genome profiling of ovarian adenocarcinomas using pangenomic BACs microarray comparative genomic hybridization

Name Segmental gain Segmental loss Other abnormalities
l PG Segmental gain on 2p, 7q, and 13 q arms Mosaic segmental loss on 10 q and 18 q arms  
2 TS Segmental gain on 8q, 9q, 12p, and 13q arms Total loss of 9p and 10q arms Monosomy 21 and 22
3 VM Mosaic segmental gain on 3q and 4q arms Total gain of 7q, 8q, 9q, 13q arms Mosaic segmental loss on 6q arms Monosomy 22
4 LR Mosaic segmental gain on 3q and 4q Total gain of 2p, 7q, 8q, 9q 13q and 17q arms Mosaic segmental loss on 6q arms Monosomy 21
5 AW Segmental gain on 12p arms Total loss of chromosome 10 Segmental disorder of chromosome 13 monosomy 21 and X
6 FR Segmental gain on 8q, 9q, 12p and 13q arms Segmental loss on 9p arm Monosomy 22 and X
7 PL Segmental gain on 2p, 7q, 8q, 9q, 12p,13q arms Mosaic segmental loss on 6q, 7p and 10p arms  
8 MA Segmental gain on 2p, 8q and 9q arms Mosaic segmental gain on 12p arm Segmental loss on 9p arm Cryptic loss of tel 17p
9 MF Segmental gain on 8q and 9q arms Mosaic segmental gain 12p arm Segmental loss on 9p arm Cryptic loss of tel 17p
10 WDT Segmental gain on 8q, 9q and 13q arms Segmental mosaic loss on 6q arm Monosomy 22